Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol. 2014;20(3):274-282.   Published online 2014 Sep 25     DOI: https://doi.org/10.3350/cmh.2014.20.3.274
Citations to this article as recorded by Crossref logo
Blood Levels of Glutamine and Nitrotyrosine in Patients with Chronic Viral Hepatitis
Hussam Murad, Haythum O Tayeb, Mahmoud Mosli, Misbahuddin Rafeeq, Mohammed Basheikh
International Journal of General Medicine.2021; Volume 14: 8753.     CrossRef
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clinical and Molecular Hepatology.2016; 22(2): 241.     CrossRef